<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Terms of Service - Clonal Hematopoiesis Risk Score</title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
            line-height: 1.6;
            color: #333;
            max-width: 800px;
            margin: 0 auto;
            padding: 20px;
        }
        h1, h2 {
            color: #2c3e50;
        }
        h1 {
            border-bottom: 2px solid #3498db;
            padding-bottom: 10px;
        }
        h2 {
            margin-top: 30px;
        }
        h3 {
            margin-top: 20px;
        }
    </style>
</head>
<body>
    <h1>Terms of Service</h1>
    <p><strong>Effective Date:</strong> December 2024<br>
    <strong>Last Updated:</strong> December 2024</p>

    <h2>1. Acceptance of Terms</h2>
    <p>By downloading, installing, or using the Clonal Hematopoiesis Risk Score mobile application ("the App"), you agree to be bound by these Terms of Service ("Terms"). If you do not agree to these Terms, do not use the App.</p>

    <h2>2. Eligibility</h2>
    <ul>
        <li>You must be at least 17 years of age to use this App</li>
        <li>You must be a qualified healthcare professional</li>
        <li>By using the App, you represent and warrant that you meet these eligibility requirements</li>
    </ul>

    <h2>3. Description of Service</h2>
    <p>The App provides:</p>
    <ul>
        <li>Implementation of the Clonal Cytopenia Risk Score (CCRS) based on Xie et al. (Blood, 2024)</li>
        <li>Implementation of the Clonal Hematopoiesis Risk Score (CHRS) based on Weeks et al. (NEJM Evidence, 2023)</li>
        <li>Risk calculations for therapy-related myeloid neoplasms in patients with clonal hematopoiesis</li>
    </ul>

    <h2>4. Medical Professional Use Only</h2>
    
    <h3>4.1 Intended Users</h3>
    <p>This App is designed exclusively for use by qualified healthcare professionals including but not limited to:</p>
    <ul>
        <li>Physicians</li>
        <li>Nurse practitioners</li>
        <li>Physician assistants</li>
        <li>Medical researchers</li>
        <li>Other licensed healthcare providers</li>
    </ul>

    <h3>4.2 Not Medical Advice</h3>
    <ul>
        <li>The App is a clinical decision support tool only</li>
        <li>It does not provide medical diagnosis, treatment, or advice</li>
        <li>All results must be interpreted in the context of complete clinical assessment</li>
        <li>The App should not replace professional medical judgment</li>
    </ul>

    <h2>5. Acceptable Use</h2>
    <p>You agree to use the App only for:</p>
    <ul>
        <li>Clinical decision support in appropriate medical settings</li>
        <li>Educational purposes related to patient care</li>
        <li>Research purposes as appropriate</li>
    </ul>
    
    <p>You agree NOT to:</p>
    <ul>
        <li>Use the App for direct patient care without appropriate clinical context</li>
        <li>Share the App with non-healthcare professionals</li>
        <li>Modify, reverse engineer, or create derivative works from the App</li>
        <li>Use the App for any unlawful purpose</li>
    </ul>

    <h2>6. Intellectual Property</h2>
    
    <h3>6.1 App Ownership</h3>
    <p>The App and its original content, features, and functionality are owned by Dae Hyun Lee, MD and are protected by international copyright, trademark, and other intellectual property laws.</p>

    <h3>6.2 Algorithm Attribution</h3>
    <p>The medical algorithms implemented in this App are based on published research:</p>
    <ul>
        <li>CCRS Algorithm: Xie et al., "Risk prediction for clonal cytopenia: multicenter real-world evidence" Blood (2024)</li>
        <li>CHRS Algorithm: Weeks et al., "Prediction of risk for myeloid malignancy in clonal hematopoiesis" NEJM Evidence (2023)</li>
    </ul>

    <h2>7. Disclaimer of Warranties</h2>
    <p>THE APP IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO:</p>
    <ul>
        <li>MERCHANTABILITY</li>
        <li>FITNESS FOR A PARTICULAR PURPOSE</li>
        <li>NON-INFRINGEMENT</li>
        <li>ACCURACY OR RELIABILITY OF RESULTS</li>
    </ul>

    <p>We do not warrant that:</p>
    <ul>
        <li>The App will meet your specific requirements</li>
        <li>The App will be uninterrupted, secure, or error-free</li>
        <li>The results will be accurate or reliable for any specific patient</li>
    </ul>

    <h2>8. Limitation of Liability</h2>
    <p>IN NO EVENT SHALL DAE HYUN LEE, MD, THE UNIVERSITY OF PENNSYLVANIA, OR ANY AFFILIATES BE LIABLE FOR:</p>
    <ul>
        <li>Any indirect, incidental, special, consequential, or punitive damages</li>
        <li>Any loss of profits, data, use, goodwill, or other intangible losses</li>
        <li>Any damages related to your use or inability to use the App</li>
        <li>Any damages related to clinical decisions made using the App</li>
    </ul>

    <h2>9. Indemnification</h2>
    <p>You agree to indemnify, defend, and hold harmless Dae Hyun Lee, MD and affiliates from any claims, liabilities, damages, losses, and expenses arising from:</p>
    <ul>
        <li>Your use or misuse of the App</li>
        <li>Your violation of these Terms</li>
        <li>Your violation of any third-party rights</li>
        <li>Any clinical decisions made using the App</li>
    </ul>

    <h2>10. Privacy</h2>
    <p>Your use of the App is also governed by our Privacy Policy. Please review our Privacy Policy, which explains that we do not collect, store, or transmit any personal or patient data.</p>

    <h2>11. Updates and Modifications</h2>
    
    <h3>11.1 App Updates</h3>
    <p>We may update the App from time to time to:</p>
    <ul>
        <li>Reflect changes in medical literature</li>
        <li>Improve functionality</li>
        <li>Fix bugs or errors</li>
        <li>Comply with legal requirements</li>
    </ul>

    <h3>11.2 Terms Modifications</h3>
    <p>We reserve the right to modify these Terms at any time. Changes will be effective immediately upon posting the updated Terms.</p>

    <h2>12. Termination</h2>
    <p>We may terminate or suspend your access to the App immediately, without prior notice, for any reason, including without limitation if you breach these Terms.</p>

    <h2>13. Governing Law</h2>
    <p>These Terms shall be governed by and construed in accordance with the laws of Pennsylvania, United States, without regard to its conflict of law provisions.</p>

    <h2>14. Severability</h2>
    <p>If any provision of these Terms is found to be invalid or unenforceable, the remaining provisions will continue to be valid and enforceable.</p>

    <h2>15. Contact Information</h2>
    <p>For questions about these Terms, please contact:</p>
    <p><strong>Dae Hyun Lee, MD</strong><br>
    Email: daehyun.lee@pennmedicine.upenn.edu<br>
    Institution: University of Pennsylvania</p>

    <h2>16. Acknowledgment</h2>
    <p>BY USING THE APP, YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS OF SERVICE, UNDERSTAND THEM, AND AGREE TO BE BOUND BY THEM.</p>
</body>
</html>
